According to Antares Pharma's latest financial reports the company's current earnings are C$0.18 Billion. In 2021 the company made an earning of C$94.73 Million, an increase over its 2020 earnings that were of C$19.71 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2021 | C$94.73 M | 380.61% |
2020 | C$19.71 M | 800.66% |
2019 | C$2.18 M | -139.64% |
2018 | -C$5.53 Million | -74.93% |
2017 | -C$22.03 Million | -36.47% |
2016 | -C$34.68 Million | 17.86% |
2015 | -C$29.43 Million | -41.73% |
2014 | -C$50.49 Million | 68.41% |
2013 | -C$29.99 Million | 82.08% |
2012 | -C$16.47 Million | 158.1% |
2011 | -C$6.38 Million | -26.38% |
2010 | -C$8.67 Million | -37.83% |
2009 | -C$13.94 Million | -20.53% |
2008 | -C$17.54 Million | 41.09% |
2007 | -C$12.44 Million | 4.46% |
2006 | -C$11.91 Million | -3.64% |
2005 | -C$12.36 Million | 2.56% |
2004 | -C$12.05 Million | -3% |
2003 | -C$12.42 Million | -15.86% |
2002 | -C$14.76 Million | 19.01% |
2001 | -C$12.4 Million | 76.98% |
2000 | -C$7.01 Million | 34.92% |
1999 | -C$5.2 Million | -40.27% |
1998 | -C$8.7 Million | 75.75% |
1997 | -C$4.95 Million | 40.65% |
1996 | -C$3.52 Million |